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Signaling lymphocytic activation molecule (SLAM)-associated protein (SAP) plays an essen-
tial role in the immune system mediating the function of several members of the SLAM
family (SLAMF) of receptors, whose expression is essential forT, NK, and B-cell responses.
Additionally, the expression of SAP in double-positive thymocytes is mandatory for natural
killer T (NKT) cells and, in mouse, for innate CD8+ T cell development. To date, only two
members of the SLAMF of receptors, Slamf1 and Slamf6, have been shown to positively
cooperate during NKT cell differentiation in mouse. However, it is less clear whether other
members of this family may also participate in the development of these innate T cells.
Here, we show that Slamf[1+6]−/− and Slamf[1+5+ 6]−/− B6 mice have ~70% reduction
of NKT cells compared to wild-type B6 mice. Unexpectedly, the proportion of innate CD8+
T cells slightly increased in the Slamf[1+5+6]−/−, but not in the Slamf[1+6]−/− strain,
suggesting that Slamf5 may function as a negative regulator of innate CD8+ T cell devel-
opment. Accordingly, Slamf5−/− B6 mice showed an exclusive expansion of innate CD8+
T cells, but not NKT cells. Interestingly, the SAP-independent Slamf7−/− strain showed an
expansion of both splenic innate CD8+T cells and thymic NKT cells. On the other hand, and
similar to what was recently shown in Slamf3−/− BALB/c mice, the proportions of thymic
promyelocytic leukemia zinc finger (PLZFhi) NKT cells and innate CD8+ T cells significantly
increased in the SAP-independent Slamf8−/− BALB/c strain. In summary, these results
show that NKT and innate CD8+ T cell development can be regulated in a SAP-dependent
and -independent fashion by SLAMF receptors, in which Slamf1, Slamf6, and Slamf8 affect
development of NKT cells, and that Slamf5, Slamf7, and Slamf8 affect the development of
innate CD8+ T cells.
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INTRODUCTION
During mainstream T lymphocyte development, some of the
key factors that drive the transition from double-positive (DP)
CD4+CD8+ precursors to single positive (SP) T cells involve
antigen specificity and TCR strength (1–3). During this process,
thymic epithelial cells interact with DP cells to determine the fate
of immature thymocytes by orchestrating positive and negative
selection (4–7). By contrast, homotypic DP–DP interactions drive
development and selection of the so-called innate αβ T lympho-
cytes, which include natural killer T (NKT) and innate CD8+ T
cells (8–10). During development in the thymus, as well as in
the effector phase in the periphery, NKT and innate CD8+ T cells,
which have a restricted TCR repertoire, interact with different non-
classical MHC class I molecules (11–14). These cells are thought to
be the first responder cells that can rapidly release various cytokines
and control both viral and bacterial infections (15).
Signaling lymphocytic activation molecule (SLAM)-associated
protein (SAP) (encoded by Sh2d1a in mouse) and several SLAM
family (SLAMF) receptors provide DP thymocytes with posi-
tive signals that favor their maturation in the thymus (16–20).
Cognate activation of NKT cells is restricted to CD1d–lipid com-
plexes and is modulated by SAP and at least three members of
the SLAMF of receptors (20–22). The homophilic interactions
of Slamf1 and Slamf6 between DP thymocytes are particularly
important for the development of the NKT cell lineage (20). Bind-
ing of SAP to the immunoreceptor tyrosine-based switch motifs
(ITSMs) present in the cytoplasmic tail of several SLAMF receptors
(23–25) promotes a unique interaction between the active config-
uration of the Src tyrosine kinase Fyn and the SLAMF receptor
(26, 27), while at the same time blocking the recruitment of the
protein phosphatases SHP-1 and SHP-2 (28–30), leading to effi-
cient T cell activation and survival (31, 32). Recent evidence now
demonstrates that Slamf3, another SAP-associated SLAMF recep-
tor, acts as an inhibitory receptor for NKT and innate CD8+ T cell
development (22). This suggests that differential SLAMF recep-
tor expression can positively or negatively influence innate T cell
development.
Non-conventional innate CD8+ T cells are also selected in the
thymus from DP progenitors upon interaction with hematopoietic
cells. Their TCR specificity is restricted to non-classical MHC class
Ib molecules, including H2-M3 (histocompatibility 2, M region
locus 3), Qa-1 (H2-T23), and MR1 (MHC class I related) (15).
Like NKT cells, innate CD8+ T cells bear an activated pheno-
type (CD44hiCD122+) and promptly produce interferon-gamma
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(IFN-γ) upon activation. Moreover, positive selection of these
innate CD8+ T cells in the thymus strictly depends on interleukin
(IL)-15 (33–36). These lymphocytes have been most extensively
described in Rlk−/−Itk−/− (resting lymphocyte kinase/iterleukin-
2-inducible T cell kinase) and Itk−/− B6 mice, where these kinases
are believed to set the threshold of TCR activation during lin-
eage commitment. Hence, T cell clones with high MHC affinity
will escape negative selection and acquire innate-like features (3,
15, 37–39). Notably, the expansion of these cells in Itk−/− mice,
and in other deficient B6 mouse strains with a similar phenotype
(10, 40) depends on a subset of thymic promyelocytic leukemia
zinc finger (PLZFhi) NKT cells producing IL-4 (41–43). Impor-
tantly, this process also requires an intact SAP expression in the
hematopoietic compartment (41). Sensing of IL-4 by developing
innate CD8+ T cells upregulates one of the key transcription fac-
tors involved in the acquisition of the innate-like program by these
cells, the T-box transcription factor, Eomesodermin (Eomes) (42–
46). In turn, Eomes directs the expression of granzyme B, perforin,
IFN-γ and, importantly, the expression of the IL-2/IL-15 receptor
β chain, CD122, which conveys responsiveness to the cytokine
IL-15 (44).
Mutations in the human SH2D1A gene lead to X-linked lym-
phoproliferative syndrome (XLP) (28). This rare inherited disor-
der is characterized by exaggerated T- and B-cell responses against
Epstein–Barr virus (EBV), resulting in EBV-induced infectious
mononucleosis, hypogammaglobulinemia, and a higher risk of
developing various forms of lymphoma. Because patients with
XLP lack NKT cells, the study of the regulation of their devel-
opment and function by SLAMF receptors and SAP will shed
light on the pathogenesis of this often-fatal disease. An important
unanswered question in this field relates to how the coexpression
of different arrays of SLAMF receptors favors the development
of a particular innate T cell lineage. Therefore, in this study, we
aimed to evaluate the relative contributions of three SAP-binding
receptors, Slamf1, Slamf5, and Slamf6, and two SAP-independent
receptors, Slamf7 and Slamf8, to the development of NKT and
innate CD8+ T cells in the mouse.
MATERIALS AND METHODS
MICE
Slamf[1+ 6]−/− and Slamf[1+ 5+ 6]−/−mice on a C57BL/6 (B6)
are described by Wang et al. (manuscript submitted for publi-
cation). Jα18−/− mice on a B6 background, originally from Dr.
Taniguchi (Riken, Yokohama, Japan), were provided by Dr. Exley
(Beth Israel Deaconess Medical Center (BIDMC), Harvard Med-
ical School, Boston, MA, USA). Slamf7−/− B6 mice (B6N.129S5-
Slamf7tm1Lex/Mmucd, identification number 032574-UCD) were
obtained from the Mutant Mouse Regional Resource Center
(MMRRC), an NIH-funded strain repository, and was donated
to the MMRRC by Genentech, Inc., Sh2d1a−/− mice on B6
and BALB/c backgrounds have been previously described (47).
Slamf8−/− mice on a BALB/c background have been previously
described (48). Age- and sex-matched controls on the B6 and
BALB/c backgrounds were purchased from The Jackson Labora-
tory (Bar Harbor, ME, USA) or from Charles River Laboratories
(Wilmington, MA, USA). All animals were housed in the Center
for Life Science animal facility of the BIDMC. The experiments
were performed according to the guidelines of the Institutional
Animal Care and Use Committee at BIDMC.
GENERATION OF SLAMF5−/− MICE
A B6 background murine bacterial artificial chromosome (BAC)
clone (BAC RP23-77A8) was used as the PCR template for cloning
the 5′, 3′ arm and middle homologous fragments of the target-
ing vector. The PCR primers for the 6-kb 5′ targeting arm were
designed from the upstream sequence of exon 1. The 2.1-kb mid-
dle arm that contains the promoter region plus exon 1, and the
4-kb 3′ arm intron 1 fragments were generated by PCR. The PCR
products were cloned into a targeting vector containing a LoxP-
FRT-Neo-FRT-LoxP cassette (Figure 2A). The resulting targeting
construct was sequenced to confirm the correct sequences and ori-
entation of the inserted PCR fragments. The targeting vector was
then incorporated into Bruce 4 ES cells by electroporation. South-
ern blot hybridization was performed with a 5′ external probe
to detect the homologous recombination event, and the positive
clones were confirmed using a 3′ external probe. Four indepen-
dent positive ES clones were microinjected into blastocysts from
BALB/c mice and gave rise to germline transmission of the Slamf5
mutant DNA. The resulting mice were bred with FLP transgenic
B6 mice. FLP-mediated recombination resulted in the deletion of
the FRT-flanked Neo gene. Subsequently, Neo-free mice were bred
with CreTg mice to generate Slamf5−/− mice (Figures 2A,B).
ANTIBODIES, TETRAMERS, AND FLOW CYTOMETRY
PLZF (Mags.21F), Eomes (Dan11mag), TCRβ (H57-597), CD3
(17A2), and CD122 (TM-b1) antibodies were purchased from
eBioscience (San Diego, CA, USA). CD4 (RM4.5), CD8α (53–
6.7), CD44 (IM7), IFN-γ (XMG1.2), Slamf3 (CD229), and Slamf5
(CD84) antibodies were purchased from BioLegend (San Diego,
CA, USA). Slamf1 (CD150), Slamf2 (CD48), Slamf4 (CD244), and
Slamf6 (CD352) antibodies were purchased from BD Pharmin-
gen (San Diego, CA, USA). PBS-57-loaded CD1d tetramers were
provided by the National Institutes of Health tetramer facility
(Atlanta, GA, USA). Briefly, 2–5× 106 thymocytes or splenocytes
were incubated with the relevant cocktail of antibodies for 30 min
on ice, washed twice with PBS+ 5% FCS+ 5 mM EDTA, and
acquired on a BD™ LSR II flow cytometer (BD Biosciences, San
Jose, CA, USA). Dead cells were excluded by DAPI (Invitrogen,
Carlsbad, CA, USA) or by using the Fixable Viability Dye eFluor®
455UV reagent (eBioscience). Data analysis was performed using
FlowJo software (TreeStar, Ashland, OR, USA). For specific details
concerning the FACS gating strategy used in this manuscript, refer
Figures S1 and S2 in Supplementary Material. To accurately iden-
tify the background levels of CD122, CD44, Eomes, and PLZF from
the true positive population, the fluorescence minus one (FMO)
approach, in which all dyes except for the one of interest are added
to the samples, was used in all the FACS analysis (49–51).
INTRACELLULAR STAINING
After surface staining (including the Fixable Viability Dye eFluor®
455UV), cells were fixed in IC/Fixation buffer (eBioscience) and
then incubated for 30 min on ice with anti-PLZF plus anti-Eomes
antibodies in 1× permeabilization buffer (eBioscience). After
several washes, the cells were acquired on a BD™ LSR II flow
cytometer (BD Biosciences).
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EX VIVO CELL ACTIVATION AND INTRACELLULAR CYTOKINE STAINING
Total thymocytes from wild-type (WT) or Slamf8−/− BALB/c mice
were incubated overnight at 37°C in the presence of the Cell
Stimulation Cocktail (plus protein transport inhibitors) reagent
(eBioscience). After surface staining (including the Fixable Via-
bility Dye eFluor® 455UV), cells were fixed/permeabilized and
incubated for 30 min with anti-IFN-γ antibody on ice. Samples
were acquired on a BD™ LSR II flow cytometer. Data analysis was
performed using FlowJo software.
RNA ISOLATION AND REAL-TIME PCR (qPCR)
Total RNA was isolated using TRIzol® LS reagent (Invit-
rogen) and precipitated with isopropanol. All RNA samples
were tested in duplicates, at 50 ng/well, using the One-Step
Real-Time RT-PCR Master Mix Reagent (Applied Biosystems®,
Part Number 4309169). qPCR was performed and analyzed
on the 7500 FAST Real-Time PCR System (Applied Biosys-
tems®). Slamf8 (Mm01293286_m1), Eomes (Mm01351985_m1),
Zbtb16 (Mm01176868_m1), Irf4 (Mm00516431_m1), IL-4
(Mm00445259_m1), and the Eukaryotic 18S ribosomal RNA
Endogenous Control TaqMan® probes were purchased from Life
Technologies (Carlsbad, CA, USA). The relative gene-specific fold
change, normalized to 18S rRNA, was calculated using the 2−∆∆ct
method and expressed relative to WT levels (WT= 1).
STATISTICAL ANALYSIS
Statistical significance was determined by unpaired t -test (two-
tailed with equal SD) using Prism software (GraphPad, San
Diego, CA, USA). The p value <0.05 was considered statistically
significant.
RESULTS
DIFFERENTIAL EXPRESSION OF SLAMF RECEPTORS BY MOUSE
THYMOCYTE SUBSETS
Since both NKT and innate CD8+ T cells are selected from homo-
typic interactions between DP thymocytes, we thought that it
was relevant to determine the specific SLAMF receptor expres-
sion pattern of these cells (Figure S1 in Supplementary Material).
As previously reported (20, 22), we found that the homotypic SAP-
dependent receptors Slamf1, Slamf3, Slamf5, and Slamf6 are mod-
erately to highly expressed by DP TCRβlow thymocytes. Although
Slamf2 is highly expressed by these cells, its receptor, Slamf4, is
virtually absent, suggesting that this heterophilic interaction does
not play a role during homotypic DP-DP contacts (Figure S1D
in Supplementary Material). On the other hand, CD44hiNK1.1+
mature thymic NKT cells showed less Slamf1 and Slamf6 expres-
sion than their DP progenitors, while Slamf2, Slamf3, Slamf4, and
Slamf5 were upregulated (Figure S1D in Supplementary Mater-
ial). Thymic innate CD8+ T cells maintained the levels of Slamf1,
Slamf4, and Slamf6 expression compared to DP TCRβlow thymo-
cytes, but slightly upregulated Slamf2, Slamf3, and Slamf5 (Figure
S1D in Supplementary Material). Once in the spleen, mature NKT
cells expressed Slamf1, Slamf5, and Slamf6 at a higher level than
in the thymus, but lacked Slamf4 expression. Slamf2 and Slamf3
levels did not change on these cells. With the exception of Slamf1
and Slamf6, which were downregulated, the other SLAMF recep-
tors showed a similar level of expression in splenic innate CD8+
T cells compared to their thymic counterparts (Figure S1D in
Supplementary Material). Together, these data suggest that the
SAP-dependent receptors Slamf1, Slamf3, Slamf5, and Slamf6 may
participate in early homotypic cell–cell interactions leading to
NKT and/or innate CD8+ T cell differentiation.
SAP-INDEPENDENT RECEPTORS SLAMF7 AND SLAMF8 ARE HIGHLY
EXPRESSED IN THYMIC-RESIDENT DENDRITIC CELLS
We used the Gene Skyline tool from the Immunological Genome
Project’s website [Immgen.org; (52)] to determine Slamf7, Slamf8,
and Slamf9 mRNA expression levels by different thymic popu-
lations (Table 1). Slamf7 mRNA was differentially expressed by
mature NKT cells, dendritic cells (DC), and medullary epithelial
cells, while Slamf8 mRNA was only present in DC and thymic
fibroblasts, but not in DP thymocytes. Slamf9 mRNA was moder-
ately expressed by DP thymocytes, DC, and medullary epithelial
cells only. Furthermore, Sh2d1a mRNA (encoding SAP) was only
detected in DP and mature NKT cells, while Sh2d1b1 mRNA
(encoding EAT-2A) was not expressed by any of the cell subsets
analyzed. These data suggest that the SAP-independent SLAMF
receptors, Slamf8 and Slamf9, may also modulate innate T cell
differentiation in mice.
SLAMF1 AND SLAMF6 CONTROL NKT BUT NOT INNATE CD8+ T CELL
DEVELOPMENT
Although disruption of Slamf1 or Slamf6 gene only margin-
ally affects NKT cell development (20) (Table 2), the use of
mixed-bone marrow chimeras or a lentivirus-based knockdown
approach have suggested that these SLAMF receptors positively
cooperate during NKT cell differentiation (20, 53). Therefore, to
better understand the consequences of a combined deficiency of
more than one SLAMF receptor during innate T cell develop-
ment, we generated Slamf[1+ 6]−/− and Slamf[1+ 5+ 6]−/− B6
mice by two sequential homologous recombination-based gene
disruptions (Wang et al., manuscript submitted for publication).
Both Slamf[1+ 6]−/− and Slamf[1+ 5+ 6]−/− B6 mice devel-
oped normally and had no gross phenotype as compared to their
WT littermates (Wang et al., manuscript submitted for pub-
lication). Consistent with the outcomes of our previous bone
Table 1 | mRNA levels in SAP-independent SLAMF receptors and
SLAMF adaptors expressed by different murine thymic populations.
Cell subset Slamf7 Slamf8 Slamf9 Sh2d1a Sh2d1b1
DP thymocytes − − + + −
Mature NKT ++ − − + −
CD8− DC +++ ++ + − −
CD8+ DC +++ ++ + − −
Medullary epithelial cells + − + − −
Thymic fibroblasts − + − − −
DP thymocyte: CD4+CD8+TCRβ−/lowCD69−; mature NKT: TCRβ+PBS-57-CD1d-
Tet+CD44+NK1.1+; DC: CD11c+MHC-II+CD11b−CD4−; medullary epithelial cells:
CD45-EpCAM+Ly51−MHC-IIhi; thymic fibroblast: CD45-PDGFRα+MTS15+. Sym-
bols represent the relative normalized mRNA levels (arbitrary units) according to
the following criteria: (−), <50; (+), 50–500; (++), 500–1000; (+++), >1000.
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Table 2 | Effects of SAP and SLAMF receptor deficiencies on innateT cell development in the thymus of B6 mice.
C57BL/6 Sh2d1a−/− F1−/− F5−/− F6−/− F[1+6]−/− F[1+5+6]−/− F3−/− F7−/−
Mature NKT ↓↓↓ ↓ ± ↓ ↓↓ ↓↓ ↑ ↑
Innate CD8 ↑ ? ± ? ± ± = =
References (17–19, 40, 41, 53–55) (20, 56, 57) This work (20, 53, 56) This work and (20) This work (22, 58) This work
↓, Reduction; ↑, expansion; ±, marginal/some effect; =, no effect; ?, no data available.
marrow chimera experiments (20), NKT cell development was
severely impaired as judged by a 70% reduced frequency and
absolute cell counts (data not shown) of PBS-57 CD1d-tetramer
(CD1d-Tet) reactive cells (NKT) both in the thymus and spleen of
Slamf[1+ 6]−/− and Slamf[1+ 5+ 6]−/− B6 mice (Figures 1A,B).
Importantly, these results further confirm the significance of
Slamf1 and Slamf6 coexpression in DP thymic precursors for NKT
cell development. Since the additional disruption of the Slamf5
gene in the triple-knockout strain did not further reduce the NKT
cell compartment (Figures 1A,B), we conclude that in the absence
of Slamf1 and Slamf6, Slamf5 does not play a major role in NKT
cell differentiation.
As NKT cells have been shown to support innate CD8+ T cell
development (10, 43), we hypothesized that both Slamf[1+ 6]−/−
and Slamf[1+ 5+ 6]−/− B6 mice would present a marked reduc-
tion in the proportions of innate CD8+T cells due to the dra-
matic loss of NKT cells (Figures 1A,B). Unexpectedly, we did
not find a significant impairment of the innate CD8+ T cell
pool (CD44hiCD122+) in the thymus of Slamf[1+ 6]−/− or
Slamf[1+ 5+ 6]−/− B6 mice (Figures 1C,D). Instead, we found a
slight increase of splenic innate-like CD8+ T cells in the absence
of Slamf1, Slamf5, and Slamf6 (Figures 1C,D). These results
raised the possibility that Slamf5 could be acting as a SAP-
dependent negative regulator of innate CD8+ T cell expansion
in the periphery.
The above findings also suggest that the requirement of NKT
cells during innate CD8+ T cell development and/or expansion is
not absolute. To test this, we looked for the presence of innate-
like CD8+ T cells in Jα18−/− B6 mice, which, like Sh2d1a−/−
B6 mice, completely lack NKT cells (59). Similar to what we
found in Slamf[1+ 5+ 6]−/− mice (Figures 1C,D), Jα18−/− B6
mice did not present significant alterations in the innate CD8+
T cell compartment, showing similar percentages of these cells
both in the thymus and spleen compared to WT (Figures 1E,F).
Intriguingly, although SAP was shown to be required for the selec-
tion of innate-like CD8+ T cells in the Itk−/− background (40),
we found a significant increase of these cells in the thymus of
Sh2d1a−/− B6 mice (Figures 1E,F). Together, these results show
that in the absence of NKT cells, innate-like CD8+ T cells can
develop relatively normally in the thymus and spleen of B6 mice.
SLAMF5 IS A NEGATIVE REGULATOR OF INNATE CD8+ T CELL
EXPANSION
The enlarged population of CD44hiCD122+ CD8+ T cells found
in the spleen of Slamf[1+ 5+ 6]−/− mice but not in the spleen
of Slamf[1+ 6]−/− mice (Figures 1C,D) prompts us to assess
whether the Slamf5/SAP axis could be negatively regulating the
development of these non-conventional lymphocytes. Therefore,
we used the single-knockout Slamf5−/− mouse to check this
hypothesis (Figures 2A,B). Indeed, we found a significant increase
in the percentage and absolute counts (data not shown) of innate-
like CD8+ T cells in the spleen of Slamf5−/−mice compared to WT
B6 mice. In the thymus, we observed a similar trend, but this result
did not reach statistical significance (Figures 2C,D). However,
the NKT cell compartment of Slamf5−/− mice appeared slightly
reduced by the absence of this receptor (Figures 2E,F). Together,
these data suggest that the SAP-binding receptor Slamf5 may be
acting as a negative regulator of innate CD8+ T cell development
and/or expansion in B6 mice (Table 2).
SAP-INDEPENDENT RECEPTOR SLAMF7 NEGATIVELY CONTROLS THE
DEVELOPMENT OF INNATE LYMPHOCYTES IN B6 MICE
Next, we evaluated whether Slamf7 deficiency (Figures 3A,B)
could also alter the innate CD8+ and/or NKT cell compartment
of B6 mice. We found a significant expansion of CD44hiCD122+
innate-like CD8+ T cells in the spleen but not in the thymus of
Slamf7−/− mice as compared to WT B6 controls (Figures 3C,D).
In contrast, and as shown in Figures 1E,F, Sh2d1a−/− B6 mice
displayed a clear expansion of CD44hiCD122+ innate-like CD8+
T cells in the thymus (Figures 3C,D). We also observed a sig-
nificant increase of CD44hi mature NKT cells in the thymus
of Slamf7−/− mice (Figures 3E,F). As expected, Sh2d1a−/− B6
mice almost completely lack mature NKT cells (Figures 3E,F).
These results suggest that endogenous expression of Slamf7
negatively influences the fate of both innate CD8+and NKT
cells. Whether this occurs via EAT-2A, a second adaptor that
was shown to bind the Slamf7 receptor (23, 24) or via SAP
recruitment to the cytoplasmic tail of Slamf7 remains to be
determined.
EXPANSION OF INNATE-LIKE T CELLS IN SLAMF8−/− BALB/c MICE
To date, nothing is currently known about the contribution of
the SAP-independent receptor Slamf8 during T cell development.
Thus, in order to test whether the lack of Slamf8 may influence
this process, we systematically identified specific T cell subsets
present in the thymus and spleen of Slamf8−/− BALB/c mice by
FACS (Figure 4E; Figure S2A in Supplementary Material). We
also included SAP-deficient BALB/c mice (Sh2d1a−/− BALB/c) in
these studies in order to evaluate the role of this SLAMF adaptor
in a murine background other than B6. We readily identified an
expansion of TCRβhi CD8SP T cells in the thymus of Slamf8−/−
mice compared to WT BALB/c mice. This alteration appeared to
be specific for this organ, as this was not observed in the spleen of
Slamf8−/− mice (expressed as a CD8:CD4 ratio; Figures 4A,B), a
phenotype resembling Slamf3−/− mice on the same background
(22) (Table 3).
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FIGURE 1 | Slamf1 and Slamf6 are required for NKT cell but not for
innate CD8+ T cell development. (A) Representative FACS plots showing
PBS-57 CD1d-tetramer (CD1d-Tet) reactive NKT cells from thymus or
spleen of WT, Slamf[1+6]−/− or Slamf[1+5+6]−/− B6 mice. FACS plots are
gated on live singlets lymphocytes. (B) Percentage of CD1d-Tet+TCRβinter
cells in thymus (left ) or spleen (right ) of WT, Slamf[1+6]−/− or
Slamf[1+5+6]−/− B6 mice. (C) Representative FACS plots showing the
expression of CD44 and CD122 on single positive CD8 T cells (CD8SP)
from thymus or spleen of WT, Slamf[1+6]−/− or Slamf[1+5+6]−/− B6
mice. FACS plots are gated on live singlets lymphocytes TCRβhi CD8SP
(thymus) or TCRβ+ CD8SP (spleen). (D) Percentage of CD44hiCD122+
CD8SP T cells in thymus (left ) or spleen (right ) of WT, Slamf[1+6]−/− or
Slamf[1+5+6]−/− B6 mice. (E) Representative FACS plots showing the
expression of CD44 and CD122 on CD8SP T cells from thymus or spleen of
WT, Jα18−/− or Sh2d1a−/− B6 mice. FACS plots are gated on live singlets
lymphocytes TCRβhi CD8SP (thymus) or TCRβ+ CD8SP (spleen).
(F) Percentage of CD44hiCD122+ CD8SP T cells in thymus (left ) or spleen
(right ) of WT, Jα18−/− or Sh2d1a−/− B6 mice. Numbers inside plots show
the mean percentage±SD of NKT cells (A), or innate-like CD8+ T cells
(C, E). Red rectangles in (A) depict the lymphocyte gate in which innate
CD8+ T cells were analyzed. Cumulative graphs show the results of two
independent experiments, mean±SEM. The p values were calculated by
unpaired t -test between the WT group and the knockout group. A value of
p<0.05 was considered significant; ns, non-significant.
Because of the CD8-biased T cell expansion observed in
Slamf8−/− BALB/c mice, we analyzed the intracellular expres-
sion of the CD8-specific T-box transcription factor Eomes. Con-
sistent with the above results, we found a twofold increase
in the proportion of Eomes+ CD8SP T cells in the thymus
of Slamf8−/− mice (Figures 4C,D). Interestingly, and despite
the comparable ratio of CD8:CD4 T cells found in the spleen
of Slamf8−/− mice, Eomes+ CD8SP T cells also increased in
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FIGURE 2 | Slamf5 acts as a negative modulator of innate CD8+ T cell.
(A) Schematic representation of the Slamf5 conditional targeting strategy.
Homologous recombination of the targeting construct with the Slamf5
genomic locus results in the introduction of an FRT-Neo-FRT cassette along
with two LoxP sites surrounding exon 1. Subsequent FLP- and Cre-mediated
recombination events lead to the generation of the Slamf5−/− gene.
(B) Mouse tail DNA was isolated and screened by PCR using the two sets of
primers (5FP1+5RP1 and 5FP2+5RP2) depicted in (A). Fragments of ~369
and ~300 base pairs are expected for the WT and mutant alleles, respectively.
The PCR gel shows a representative result of two WT and two Slamf5−/−
mouse DNA samples. (C) Representative FACS plots showing the expression
of CD44 and CD122 on CD8SP T cells from thymus (TCRβhi) or spleen (TCRβ+)
of WT or Slamf5−/− B6 mice. FACS plots are gated on live singlets
lymphocytes TCRβhi CD8SP (thymus) or TCRβ+ CD8SP (spleen).
(D) Percentage of CD44hiCD122+ CD8SP T cells in thymus (left ) or spleen
(right ) of WT or Slamf5−/− B6 mice. (E) Representative FACS plots showing
PBS-57 CD1d-tetramer (CD1d-Tet) reactive NKT cells from thymus or spleen
of WT or Slamf5−/− B6 mice. FACS plots are gated on live singlets
lymphocytes. (F) Percentage of CD1d-Tet+TCRβinter cells in thymus (left ) or
spleen (right ) of WT or Slamf5−/− mice. Numbers inside plots show the mean
percentage±SD of innate-like CD8+ T cells (C), or NKT cells (E). Red
rectangles in (E) depict the lymphocyte gate in which innate CD8+ T cells
were analyzed. Cumulative graphs show the results of three independent
experiments, mean±SEM. The p values were calculated by unpaired t -test
between the WT group and the Slamf5−/− group. A value of p<0.05 was
considered significant; ns, non-significant.
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FIGURE 3 | Expansion of innate CD8+ T cells in the absence of Slamf7.
(A) Schematic representation of the Slamf7−/− mice generation. The
pKOS-7 targeting vector was designed to replace a genomic fragment
containing exon 2–6 with a LacZ/Neo cassette. (B) Mouse tail DNA was
isolated and screened by PCR using the two sets of primers (7FP1+7RP1
and 7FP2+7RP2) depicted in (A). Fragments of ~248 and ~407 base pairs
are expected for the WT and mutant alleles, respectively. The PCR gel
shows a representative result of one WT and one Slamf7−/− DNA mouse
samples. (C) Representative FACS plots showing the expression of CD44
and CD122 on CD8SP T cells from thymus or spleen of WT, Slamf7−/− or
Sh2d1a−/− B6 mice. FACS plots are gated on live singlets lymphocytes
TCRβhi CD8SP (thymus) or TCRβ+ CD8SP (spleen). (D) Percentage of
CD44hiCD122+ CD8SP T cells in thymus (left ) or spleen (right ) of WT,
Slamf7−/− or Sh2d1a−/− B6 mice. (E) Representative FACS plots showing
PBS-57 CD1d-tetramer (CD1d-Tet) reactive NKT cells from thymus or
spleen of WT, Slamf7−/− or Sh2d1a−/− B6 mice. FACS plots are gated on
live singlets lymphocytes. (F) Percentage of CD1d-Tet+CD44+ cells in
thymus (left ) or spleen (right ) of WT, Slamf7−/− or Sh2d1a−/− B6 mice.
Numbers inside plots show the mean percentage±SD of innate-like CD8+
T cells (C) or NKT cells (E), mean±SEM. The p values were calculated by
unpaired t -test between the WT group and Slamf7−/− or Sh2d1a−/− group.
A value of p<0.05 was considered significant; ns, non-significant.
this organ compared to WT mice (Figures 4C,D). In contrast,
Sh2d1a−/− mice, which displayed no change in CD8:CD4 ratios
in thymus or spleen, showed a dramatic decrease in Eomes+
CD8+ T cells (Figures 4C,D). On the other hand, the relative
expression of Eomes and Irf4 (IFN regulatory factor 4) mRNA,
whose expression was shown to inversely correlate with that of
Eomes in recently activated CD8+ T cells (3, 60), did not differ
between Slamf8−/− and WT resting thymocytes (Figure 4F). In
conclusion, the absence of Slamf8 expression favors the expansion
of a CD8SP T cell population expressing Eomes in thymus and
spleen. Moreover, although the absence of SAP expression does
not alter the CD8:CD4 ratios in thymus or spleen, it dramati-
cally decreases the frequency of Eomes+ CD8SP T cells in these
organs.
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FIGURE 4 | Lack of Slamf8 expression triggers an expansion of Eomes+
CD8+ T cells. (A) Representative FACS plots showing CD4 and CD8 single
positive (SP) T cells from thymus or spleen of WT, Slamf8−/− or Sh2d1a−/−
BALB/c mice. FACS plots are gated on live singlets TCRβhi (thymus) or TCRβ+
(spleen) lymphocytes. (B) CD8:CD4 ratio of TCRβhi thymocytes (left ) or TCRβ+
splenocytes (right ) from WT, Slamf8−/− or Sh2d1a−/− BALB/c mice.
(C) Intracellular staining for the transcription factor Eomesodermin (Eomes) in
thymus or spleen of WT, Slamf8−/− or Sh2d1a−/− BALB/c mice. FACS plots are
gated on live singlets lymphocytes TCRβhi CD8SP (thymus) or TCRβ+ CD8SP
(spleen). (D) Percentage of Eomes+CD44+ CD8SP T cells in thymus (left ) or
spleen (right ) of WT, Slamf8−/− or Sh2d1a−/− BALB/c mice. (E) The relative
mRNA expression of Slamf8, or Eomes and Irf4 (F) was determined in total
thymocytes from WT or Slamf8−/− BALB/c mice by real-time PCR. Results
were normalized to the expression of the housekeeping gene 18S rRNA and
expressed relative to WT BALB/c levels (WT=1); ND, not detected. Numbers
inside plots show the mean percentage (A) or the mean percentage±SD
(C) of the indicated population. Cumulative graphs show the results of four
independent experiments, mean±SEM. The p values were calculated by
unpaired t -test between the WT group and the Slamf8−/− or Sh2d1a−/− group.
A value of p<0.05 was considered significant; ns, non-significant.
CD44hiCD122+ CD8SP T CELLS IN SLAMF8−/− MICE EXPRESS THE
TRANSCRIPTION FACTOR EOMES AND RAPIDLY PRODUCE IFN-γ UPON
STIMULATION
Consistent with the enlarged Eomes+CD8+ T cell compartment in
Slamf8−/− mice, we found a larger proportion of CD44hiCD122+
innate-like CD8+ T cells in these mice (Figures 5A,B), whereas
Sh2d1a−/− mice showed a significant reduction of these cells
in the thymus and spleen (Figures 5A,B). Interestingly, within
the thymic innate-like CD8+ T cell population, Slamf8−/− mice
showed a higher proportion of Eomes+ cells compared to WT
mice (Figures 5C,D), supporting the idea that the expanded
CD8+ T cell population documented in Figure 4 corresponds to
truly bona fide innate CD8+ T cells. Consistent with a reduced
CD44hiCD122+ CD8SP T cell population, Sh2d1a−/− BALB/c
mice displayed a dramatic reduction in Eomes+ CD8SP T cells
in the thymus and, to a lesser extent, in the spleen as well
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Table 3 | Effects of SAP and SLAMF receptor deficiencies on innateT
cell development in the thymus of BALB/c mice.
BALB/c Sh2d1a−/− F1−/− F3−/− F8−/−
Mature NKT ↓↓↓ = ↑↑↑ ±
Innate CD8 ↓↓↓ ↓↓ ↑↑↑ ↑↑↑
References This work Unpublished observations (22) This work
↓, Reduction; ↑, expansion; ±, marginal/some effect; =, no effect.
(Figures 5C,D). These seemingly contrasting results, compared
to Sh2d1a−/− B6 mice (Figures 1 and 3; Table 2), indicate that
the consequences of a SAP mutation will be greatly influenced by
the mouse background. In fact, this phenomenon was previously
observed in Slamf3−/− mice in which profound alterations of the
innate CD8+T cell compartment were only present on the BALB/c
but not on the B6 background (22, 58) (Table 3).
Finally, to confirm that the expanded population of innate-like
CD8+ T cells found in Slamf8−/− mice had the ability to produce
effector cytokines upon activation, we stimulated total thymo-
cytes ex vivo with PMA plus ionomycin. This treatment resulted
in a higher percentage of IFN-γ producing Slamf8−/− CD8SP T
cells compared to WT cells (Figures 5E,F). Together, these data
demonstrate that the lack of Slamf8 expression results in a prefer-
ential expansion of CD8+ T cells with an innate-like phenotype.
These cells express the transcription factor Eomes and produce
IFN-γ upon stimulation, suggesting that SAP-independent signals
can also modulate the generation of non-conventional CD8+ T
cells in mice.
SLAMF8−/− MICE HAVE AN ENLARGED PROPORTION OF NKT PLZFhi
CELLS IN THE THYMUS
Recent studies have strongly suggested that thymic NKT cells can
change the size of the innate CD8+ T cell pool via the pro-
duction of IL-4 (10, 22, 42, 43, 61). Therefore, we evaluated
whether we could find an expansion of NKT cells in the thy-
mus and spleen of Slamf8−/− mice. Unlike Slamf3−/− BALB/c
mice, in which an expansion of NKT cells was reported (22), we
did not observe significant differences in the percentage of total
NKT cells in the thymus or spleen of Slamf8−/− mice compared
to WT mice (Figures 6A,B). Accordingly, and consistent with an
essential role of SAP during NKT cell development on B6 mice
(17–19), Sh2d1a−/− BALB/c mice were almost completely devoid
of these cells (Figures 6A,B). These observations unmistakably
demonstrate that SAP-derived signals contribute enormously to
the NKT cell lineage commitment independently of the mouse
genetic background. Moreover, the lack of Slamf8 does not greatly
affect the proportions of CD1d-Tet reactive NKT cells.
Just as Eomes controls the effector program of innate CD8+
T cells (44), NKT cells in the thymus rely on the expression of
PLZF to gain their phenotypical and functional properties (62–
65). Although we did not observe significant differences in the
percentage of CD44hi NKT cells between WT and Slamf8−/− mice
(Figures 6A,B), the proportion of PLZFhiCD1d-Tet reactive cells
was slightly higher both in the thymus and spleen of Slamf8−/−
mice, as judged by intracellular PLZF staining (Figures 6C,D). In
contrast, we found a significant reduction of the PLZFhi popu-
lation in the few NKT cells that we could detect in Sh2d1a−/−
BALB/c mice (Figures 6C,D). However, we did not detect dif-
ferences in Zbtb16 mRNA expression (encoding PLZF) between
WT and Slamf8−/− resting thymocytes. On the other hand, an
approximately threefold increase in IL-4 mRNA (encoding IL-4)
was detected in Slamf8−/− samples (Figure 6E). Together, these
data show that the absence of Slamf8 expression licenses the expan-
sion of both Eomes+ CD8SP and PLZFhi NKT cells preferentially
in the thymus, and that those NKT cells are biased to produce IL-4,
which in turn may contribute to the expansion of innate CD8+ T
cells in Slamf8−/− mice. This proposes an unprecedented role for
the SAP-independent SLAMF receptor Slamf8 in regulating innate
T cell development.
DISCUSSION
Inadequate TCR-related signaling during T cell development,
including overly strong or weak MHC/TCR interactions, results in
the deletion of up to 90% of developing thymocytes (66). SLAMF
receptors and the adaptor SAP have been shown to play an essen-
tial modulatory role during selection of non-conventional T cells,
including NKT and innate CD8+ T cells. These homophilic inter-
actions provide developing NKT cells, and likely innate CD8+ T
cells, with both positive and negative developmental cues. Inter-
estingly, the SLAMF/SAP pathway does not seem to affect con-
ventional αβ T cell development, suggesting the existence of a
specialized mechanism by which innate lymphocytes are pref-
erentially generated in the thymus. These observations could
be partially explained by the particular modus operandi of the
SLAMF receptors, in which, as self-ligands, homotypic cell–cell
contacts can be specially favored by homophilic SLAMF–SLAMF
interactions. Additionally, as the expression of SLAMF receptors
is confined to the hematopoietic compartment, interactions of
SLAMF-expressing DP thymocytes with thymic epithelial cells
cannot lead to a productive activation of the SLAMF/SAP sig-
naling cascade in those cells. On the other hand, if two interacting
DP thymocytes display a similar SLAMF receptor expression pat-
tern, then their homophilic SLAMF–SLAMF interactions will be
particularly favored, leading to a successful expansion of these
clones.
The generation of double and triple SLAMF-deficient mouse
strains allowed us for the first time to study the simultaneous
effects of a total abolition of Slamf1, Slamf5, and Slamf6 on
NKT and innate CD8+ T cell development. Unlike our previous
experiments using mixed-bone marrow chimeras (20), these mice
provided us with the unique opportunity to avoid any possible
unwanted effects derived from the sterile inflammation induced
by the gamma radiation and/or the possible contribution of radio-
resistant cells inherent in these kinds of experiments. Since both
Slamf[1+ 6]−/− and Slamf[1+ 5+ 6]−/− mice failed to recapitu-
late the total NKT cell developmental arrest found in Sh2d1a−/−
mice (20) (Figure 1), we conclude that there must be yet another
SLAMF receptor that is able to recruit SAP in the absence of Slamf1,
Slamf5, and Slamf6. As we could not detect Slamf4 expression in
DP thymocytes, we ruled out both Slamf2 and Slamf4 from the
list of possible candidates. Since Slamf3−/− B6 mice were reported
not to have a decrease in NKT cell number (58), we can also rule
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FIGURE 5 | Slamf8−/− mice have an enlarged CD8+ T cell compartment
with innate-like features. (A) Representative FACS plots showing the
expression of CD44 and CD122 on CD8SP T cells from thymus or spleen of
WT, Slamf8−/− or Sh2d1a−/− BALB/c mice. FACS plots are gated on live
singlets lymphocytes TCRβhi CD8SP (thymus) or TCRβ+ CD8SP (spleen).
(B) Percentage of CD44hiCD122+ CD8SP T cells in thymus (left ) or spleen
(right ) of WT, Slamf8−/− or Sh2d1a−/− BALB/c mice. (C) Intracellular staining
for the transcription factor Eomesodermin (Eomes) in thymus or spleen of
WT, Slamf8−/− or Sh2d1a−/− BALB/c mice. FACS plots are gated on live
singlets lymphocytes CD44hiCD122+TCRβhiCD8SP T cells. (D) Percentage of
Eomes+ innate-like CD8+ T cells in thymus (left ) or spleen (right ) of WT,
Slamf8−/− or Sh2d1a−/− BALB/c mice. (E) Intracellular staining for IFN-γ after
ex vivo activation with PMA and ionomycin of WT or Slamf8−/− BALB/c
thymocytes. (F) Percentage of CD44hiIFN-γ+ CD8SP (left ) or CD44hi CD4SP
(right ) of WT or Slamf8−/− BALB/c thymocytes. Numbers inside plots show
the mean percentage±SD of the indicated population. Cumulative graphs
show the results of four independent experiments, mean±SEM. The p
values were calculated by unpaired t -test between the WT group and the
Slamf8−/− or Sh2d1a−/− group. A value of p<0.05 was considered significant;
ns, non-significant.
out this receptor. We then tested Slamf5−/− and Slamf7−/− B6
mice. Surprisingly, instead of a decrease in NKT and/or innate
CD8+ T cells, we found a significant increase of both these cell
populations in these mice (Figures 2 and 3), suggesting that these
receptors act as negative regulators during innate T cell develop-
ment. However, as it was shown for Slamf6 expression, in which
this receptor was able to provide both positive and negative sig-
nals to NKT cell development in a SAP-dependent manner (53),
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FIGURE 6 | Increased percentage of PLZFhi NKT cells in Slamf8−/−
mice. (A) Representative FACS plots showing PBS-57 CD1d-tetramer
(CD1d-Tet) reactive NKT cells from thymus or spleen of WT, Slamf8−/− or
Sh2d1a−/− BALB/c mice. FACS plots are gated on live singlets
lymphocytes. (B) Percentage of CD1d-Tet+TCRβinter cells in thymus (left )
or CD1d-Tet+TCRβ+ in spleen (right ). (C) Intracellular staining for the
transcription factor promyelocytic leukemia zinc finger (PLZF) in thymus
or spleen of WT, Slamf8−/− or Sh2d1a−/− BALB/c mice. FACS plots are
gated on live singlets CD1d-Tet+TCRβinter cells. (D) Percentage of PLZFhi
NKT cells in thymus (left ) or spleen (right ) of WT, Slamf8−/− or Sh2d1a−/−
BALB/c mice. (E) The relative mRNA expression of Zbtb16 (encoding
PLZF) and IL-4 (encoding Interleukin-4) was determined in total
thymocytes from WT or Slamf8−/− BALB/c mice by real-time PCR.
Results were normalized to the expression of the housekeeping gene
18S rRNA and expressed relative to WT BALB/c levels (WT=1).
Numbers inside plots show the mean percentage±SD of NKT cells (A),
or PLZFhi NKT cells for (C). Red rectangles in (A) depict the lymphocyte
gate in which innate CD8+ T cells were analyzed. Cumulative graphs
show the results of three independent experiments, mean±SEM. The p
values were calculated by unpaired t -test between the WT group and the
Slamf8−/− or Sh2d1a−/− group. A value of p<0.05 was considered
significant; ns, non-significant.
it is still possible that in the presence of other SLAMF receptors,
Slamf5 and Slamf7 play opposite roles to the signals coming from
Slamf1 and Slamf6. Further experiments will hopefully shed light
on this rather intricate but important relationship.
Interestingly, the reduction of NKT cells in Slamf[1+ 6]−/−
and Slamf[1+ 5+ 6]−/− mice, or the complete absence of these
cells in Sh2d1a−/− B6 mice, did not seem to impair the generation
of innate-like CD8+ T cells (Figure 1; Table 2). As these results
contradicted published evidence showing that NKT cells support
the expansion of innate CD8+ T cells via IL-4 production (10), and
that SAP expression is required for thymic selection of innate-like
CD8+ T cells in Itk−/− mice (40), we sought to test if the absence
of NKT cells in an otherwise normal SAP context would also affect
innate CD8+ T cell development. Hence, we analyzed the presence
of innate-like CD8+ T cells in Jα18−/− mice (Figures 1E,F). Simi-
lar to our previous observations in Sh2d1a−/− B6 mice, we did not
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detect a reduction of CD44hiCD122+ cells in this NKT-deficient
strain (Figures 1E,F), suggesting that in the absence of NKT cells
other cells can provide the factors needed to accomplish this task.
Since all murine SLAMF receptors that have one or more cyto-
plasmic ITSM, with the exception of Slamf2, Slamf8, and Slamf9,
can theoretically recruit SAP and/or EAT-2A, a redundancy in
their function during innate cell development can be expected.
Supporting this idea, none of the single SLAMF-deficient mice
generated on the B6 background have shown substantial alter-
ations in their innate T cell compartments (Table 2). Remarkably,
however, Slamf3−/− (22) and now Slamf8−/− mice (this work),
both on the BALB/c background, show massive expansions of
innate-like CD8+ T cells in the thymus (Table 3), albeit to a far
lesser extent than the Itk−/− or Rlk−/−Itk−/− B6 mice. These results
strongly suggest that the mouse background can somehow act as
a pressure selector of innate T cell development.
The recent identification of a specialized NKT cell subset
present in BALB/c mice, but practically absent in B6 mice, capable
of constantly producing IL-4 (termed NKT2), allowed Lee et al. to
propose a model in which NKT2 cells are readily available in the
thymus to secrete IL-4, resulting in intrinsically greater frequencies
of innate CD8+ T cells (43) on this mouse background. Notably,
these cells express the highest levels of PLZF among all mature
NKT cells. Consequently, an involvement of NKT2 cells in sup-
porting the expansion of innate-like CD8+ T cells in Slamf8−/−
mice can be anticipated, as we find an enlarged PLZFhi NKT pop-
ulation that correlates with a greater proportion of innate CD8+
T cells in these mice (Figures 5 and 6). However, the underlying
mechanism by which the absence of Slamf8 favors the expansion
of PLZFhi NKT cells remains undetermined. Since Slamf8 mRNA
is expressed by DC and fibroblasts in the thymus, but not DP thy-
mocytes (Table 1), we speculate that these cells may be providing
some sort of signal to developing NKT and/or innate CD8+ T cells
which is affected by the absence of Slamf8. In this context, IL-15
transpresentation has been shown to mediate survival of mature
thymic NKT and innate CD8αα+ intestinal intraepithelial T cells
(67–70). Thus, Slamf8 may be regulating the production and/or
transpresentation of this cytokine.
By investigating the impact of two previously uncharacterized
SLAMF receptors (Slamf7 and Slamf8) as well as the combined
impact of multiple SLAMF receptor deletions (Slamf[1+ 6]−/−
and Slamf[1+ 5+ 6]−/− mice), we are able to present new evi-
dence that shall complement previous knowledge concerning the
individual contributions of SLAMF receptors to NKT and innate
CD8+ T cell biology. Importantly, the outcomes of our stud-
ies show the existence of positive and negative signals derived
from different SLAMF receptors (Tables 2 and 3), which together
orchestrate innate T cell development. The cellular and molecu-
lar mechanisms behind these observations certainly deserve more
attention in the future, since these pathways could potentially
be targeted in the aid of expanding innate T cell populations
in situations where SAP is absent, such as in patients with XLP.
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Figure S1 | General gating strategy for the identification of innate (B6)T
cells, and SLAMF receptor expression by FACS. (A) Genomic organization of
the nine SLAMF genes, and the two adaptors Sh2d1b1 and Sh2d1b2 (encoding
EAT-2A and ERT, respectively) on the murine chromosome 1H3. Blue filled
boxes with a red frame represent SLAMF receptors containing one or more
ITSM. Black empty boxes represent SLAMF receptors that lack ITSM. Red and
orange boxes represent the Sh2d1b1 and Sh2d1b2 genes, respectively. This
diagram also illustrates the Slamf[1+6]−/− and Slamf[1+5+6]−/− deletions
used in this manuscript. (B) FACS plots showing the main gating strategy used
on the analysis of NKT and innate CD8+ T cells in B6 mice. Upper row from left
to right: live cells (DAPI negative), singlets, lymphocytes, and total thymocytes
depicting the NKT (CD1d-Tet+TCRβinter), the TCRβhi mature, and TCRβlow
immature thymocytes gates. Middle row from left to right: CD4+CD8+ DP
TCRβlow immature thymocytes, mature (CD44+NK1.1+) NKT cells, TCRβhi mature
T cells [depicting CD8 and CD4 single positive (SP) mature thymocytes], and
CD8SP T cells depicting the innate CD8+ T cell population in the thymus. Bottom
row from left to right, mature (CD44+NK1.1+) NKT cells, TCRβ+ T cells [depicting
CD8 and CD4 single positive (SP) splenocytes], and CD8SP T cells depicting the
innate CD8+ T cell population in the spleen. (C) Representative FACS staining of
innate CD8+ T cells (CD44hiCD122+TCRβ+) showing the corresponding
fluorescence minus one (FMO) negative control for the CD122 gate in thymus
and spleen from WT cells. (D) Representative FACS histograms showing the
expression of Slamf1, Slamf2, Slamf3, Slamf4, Slamf5, and Slamf6 on the
surface of CD4+CD8+ DP TCRβlow thymocytes (upper row, green),
CD1d-tetramer (CD1d-Tet) reactive CD44hi NKT cells (red, NKT), or on
CD44hiCD122+TCRβhi (thymus, middle row ), or TCRβ+ (spleen, bottom row )
CD8SP T cells (purple, innate-like CD8) of 10-week-old B6 mice. Gray
histograms represent the FMO negative control for the Slamf staining.
Figure S2 | General gating strategy for the identification of innate (BALB/c)
T cells by FACS. (A) FACS plots showing the main gating strategy used on the
analysis of NKT and innate CD8+ T cells in BALB/c mice. Upper row from left to
right: live cells (DAPI negative), singlets, lymphocytes, and total thymocytes
depicting the NKT (CD1d-Tet+TCRβinter), and the TCRβhi mature lymphocyte
gates. Bottom row from left to right: total live thymocytes depicting the CD8
single positive (SP), the CD4SP, and the CD4+CD8+ DP TCRβlow immature
thymocytes. (B) Representative FACS staining of innate CD8+ T cells
(CD44hiCD122+TCRβ+) showing the corresponding FMO (fluorescence minus
one) negative control for the CD122 gate (left ), or Eomesodermin (Eomes, right )
in thymus and spleen from WT cells.
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